Hyperammonemia Due to N-acetylglutamate Synthase Deficiency
📧 Sign up to get email alerts when something new happens for Hyperammonemia Due to N-acetylglutamate Synthase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-23FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carbaglumic acid) submitted by Recordati Rare Diseases. The action represents an a…